225 related articles for article (PubMed ID: 29271262)
1. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
Sridharan K; Sivaramakrishnan G; Gnanaraj J
Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
3. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses.
Cook DJ; Reeve BK; Guyatt GH; Heyland DK; Griffith LE; Buckingham L; Tryba M
JAMA; 1996 Jan 24-31; 275(4):308-14. PubMed ID: 8544272
[TBL] [Abstract][Full Text] [Related]
4. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
Krag M; Perner A; Wetterslev J; Møller MH
Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis.
Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C
J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523
[TBL] [Abstract][Full Text] [Related]
6. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
Krag M; Perner A; Wetterslev J; Wise MP; Hylander Møller M
Intensive Care Med; 2014 Jan; 40(1):11-22. PubMed ID: 24141808
[TBL] [Abstract][Full Text] [Related]
7. Current guidelines on stress ulcer prophylaxis.
Tryba M; Cook D
Drugs; 1997 Oct; 54(4):581-96. PubMed ID: 9339962
[TBL] [Abstract][Full Text] [Related]
8. Stress-related mucosal bleeding in critically ill oncology patients.
Bruno JJ; Canada TW; Wakefield CD; Nates JL
J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
[TBL] [Abstract][Full Text] [Related]
9. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
10. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate.
Tryba M
Crit Care Med; 1991 Jul; 19(7):942-9. PubMed ID: 1675976
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
12. Histamine-2-receptor antagonists and antacids in the critically ill population: stress ulceration versus nosocomial pneumonia.
Cook DJ; Reeve BK; Scholes LC
Infect Control Hosp Epidemiol; 1994 Jul; 15(7):437-42. PubMed ID: 7963434
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
Barkun AN; Bardou M; Pham CQ; Martel M
Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
[TBL] [Abstract][Full Text] [Related]
14. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials.
Huang J; Cao Y; Liao C; Wu L; Gao F
Crit Care; 2010; 14(5):R194. PubMed ID: 21034484
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.
Driks MR; Craven DE; Celli BR; Manning M; Burke RA; Garvin GM; Kunches LM; Farber HW; Wedel SA; McCabe WR
N Engl J Med; 1987 Nov; 317(22):1376-82. PubMed ID: 2891032
[TBL] [Abstract][Full Text] [Related]
16. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
Barkun AN; Adam V; Martel M; Bardou M
Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
[TBL] [Abstract][Full Text] [Related]
18. Optimal therapy for stress gastritis.
Maier RV; Mitchell D; Gentilello L
Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901
[TBL] [Abstract][Full Text] [Related]
19. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
Barletta JF; Sclar DA
Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
[TBL] [Abstract][Full Text] [Related]
20. Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia. Best evidence synthesis.
Cook DJ
Scand J Gastroenterol Suppl; 1995; 210():48-52. PubMed ID: 8578207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
